PT87068A - Process for preparing substituted benzazepines and pharmaceutical compositions containing them - Google Patents
Process for preparing substituted benzazepines and pharmaceutical compositions containing themInfo
- Publication number
- PT87068A PT87068A PT87068A PT8706888A PT87068A PT 87068 A PT87068 A PT 87068A PT 87068 A PT87068 A PT 87068A PT 8706888 A PT8706888 A PT 8706888A PT 87068 A PT87068 A PT 87068A
- Authority
- PT
- Portugal
- Prior art keywords
- alkyl
- pharmaceutical compositions
- alkoxyalkyl
- cycloalkyl
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/32—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3213587A | 1987-03-27 | 1987-03-27 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT87068A true PT87068A (pt) | 1988-04-01 |
| PT87068B PT87068B (pt) | 1992-07-31 |
Family
ID=21863286
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT87068A PT87068B (pt) | 1987-03-27 | 1988-03-24 | Processo para a preparacao de benzazepinas substituidas e de composicoes farmaceuticas que as contem |
Country Status (18)
| Country | Link |
|---|---|
| EP (2) | EP0357641A1 (pt) |
| JP (1) | JPH0662574B2 (pt) |
| KR (1) | KR930011489B1 (pt) |
| AT (1) | ATE112766T1 (pt) |
| AU (1) | AU619744B2 (pt) |
| CA (1) | CA1321195C (pt) |
| DE (1) | DE3851769T2 (pt) |
| DK (1) | DK165688C (pt) |
| FI (1) | FI894566A0 (pt) |
| HU (1) | HU205744B (pt) |
| IL (1) | IL85855A (pt) |
| MY (1) | MY103357A (pt) |
| NO (1) | NO174507B (pt) |
| NZ (1) | NZ224038A (pt) |
| PH (1) | PH27337A (pt) |
| PT (1) | PT87068B (pt) |
| WO (1) | WO1988007526A1 (pt) |
| ZA (1) | ZA882080B (pt) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK107688D0 (da) * | 1988-03-01 | 1988-03-01 | Novo Industri As | Carbaminsyreestere af substituerede 7-hydroxy-2,3,4,5-tetrahydro-1h-3-benzazepiner |
| DK67489D0 (da) * | 1989-02-14 | 1989-02-14 | Novo Industri As | Nye benzazepinderivater |
| US5068326A (en) * | 1989-04-03 | 1991-11-26 | Kung Hank F | Dopamine receptor ligands and imaging agents |
| IL98487A0 (en) * | 1990-06-15 | 1992-07-15 | Schering Corp | 8-lower alkyl-5-cycloalkyl or 5-cycloalkenyl substituted benzazepines and pharmaceutical compositions containing them |
| US5374722A (en) * | 1990-09-25 | 1994-12-20 | Schering Corporation | Bridged benzazepines |
| US5241065A (en) * | 1992-02-25 | 1993-08-31 | Schering Corporation | 2,3,4,5-tetrahydro-1h-3-benzazepines having anti-psychotic activity |
| DK1307430T3 (da) * | 2000-07-05 | 2006-01-30 | Ortho Mcneil Pharm Inc | Ikke-peptidsubstituerede spirobenzoazepiner som vasopressin-antagonister |
| US6953787B2 (en) | 2002-04-12 | 2005-10-11 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulators |
| NZ540148A (en) * | 2002-12-20 | 2007-11-30 | Glaxo Group Ltd | Benzazepine derivatives for the treatment of neurological disorders |
| WO2005035504A2 (en) | 2003-05-22 | 2005-04-21 | Schering Corporation | 5-h -benzo [d] naphth [2, 1-b] azepine derivative as selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders |
| HUE028976T2 (en) | 2003-06-17 | 2017-02-28 | Arena Pharm Inc | 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride |
| EA016558B1 (ru) * | 2003-06-17 | 2012-05-30 | Арена Фармасьютикалз, Инк. | Производные бензазепина, используемые для лечения заболеваний, ассоциированных с 5-ht-рецептором |
| AU2012200805B2 (en) * | 2003-06-17 | 2015-01-22 | Arena Pharmaceuticals, Inc. | Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases |
| US20080009478A1 (en) * | 2003-10-22 | 2008-01-10 | Arena Pharmaceuticals, Inc. | Benzazepine Derivatives and Methods of Prophylaxis or Treatment of 5Ht2c Receptor Associated Diseases |
| WO2005042490A1 (en) * | 2003-10-22 | 2005-05-12 | Arena Pharmaceuticals, Inc. | Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases |
| JP5270167B2 (ja) | 2004-12-21 | 2013-08-21 | アリーナ ファーマシューティカルズ， インコーポレイテッド | （ｒ）−８−クロロ−１−メチル−２，３，４，５−テトラヒドロ−１ｈ−３−ベンザゼピン塩酸塩の結晶形 |
| CN102631349A (zh) | 2004-12-23 | 2012-08-15 | 艾尼纳制药公司 | 5HT2c受体调节剂组合物和使用方法 |
| JP5199997B2 (ja) | 2006-04-03 | 2013-05-15 | アリーナ ファーマシューティカルズ， インコーポレイテッド | ８−クロロ−１−メチル−２，３，４，５−テトラヒドロ−１ｈ−３−ベンズアゼピンおよびこれに関連する中間体を調製するためのプロセス |
| CN101547892B (zh) | 2006-12-05 | 2014-08-20 | 艾尼纳制药公司 | 制备(r)-8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓的方法和其中间体 |
| JP5491421B2 (ja) | 2008-03-04 | 2014-05-14 | アリーナ ファーマシューティカルズ， インコーポレイテッド | ５−ｈｔ２ｃアゴニストである（ｒ）−８−クロロ−１−メチル−２，３，４，５−テトラヒドロ−１ｈ−３−ベンゾアゼピンに関連する中間体の調製のためのプロセス |
| WO2010148207A2 (en) | 2009-06-18 | 2010-12-23 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 5-ht2c receptor agonists |
| WO2011153206A1 (en) | 2010-06-02 | 2011-12-08 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 5-ht2c receptor agonists |
| SG188362A1 (en) | 2010-09-01 | 2013-04-30 | Arena Pharm Inc | Modified-release dosage forms of 5-ht2c agonists useful for weight management |
| US8999970B2 (en) | 2010-09-01 | 2015-04-07 | Arena Pharmaceuticals, Inc. | Administration of an anti-obesity compound to individuals with renal impairment |
| SG10201506870PA (en) | 2010-09-01 | 2015-10-29 | Arena Pharm Inc | Salts of lorcaserin with optically active acids |
| EP2611433A2 (en) | 2010-09-01 | 2013-07-10 | Arena Pharmaceuticals, Inc. | Non-hygroscopic salts of 5-ht2c agonists |
| KR20150070249A (ko) | 2012-10-09 | 2015-06-24 | 아레나 파마슈티칼스, 인크. | 체중 관리 방법 |
| HU230826B1 (hu) | 2014-11-19 | 2018-07-30 | Richter Gedeon Nyrt. | Eljárás benzazepin származékok előállítására |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA974989A (en) * | 1968-03-11 | 1975-09-23 | Wallace And Tiernan Inc. | Process for preparing 1,2,4,5-tetrahydro-3h,3-benzazepines and products obtained thereby |
| DE1934150A1 (de) * | 1968-07-10 | 1970-01-15 | Pennwalt Corp | Neue 1-Alkanoyloxy-1,2,4,5-tetrahydro-3H,3-benzazepine |
| US4988690A (en) * | 1982-06-14 | 1991-01-29 | Hoechst-Roussel Pharmaceuticals Inc. | 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepines and anti-depressant use thereof |
| DK180485D0 (da) * | 1985-04-22 | 1985-04-23 | Novo Industri As | Nitrogenholdige forbindelser |
| US4707483A (en) * | 1985-12-20 | 1987-11-17 | Smithkline Beckman Corporation | 1-phenyl-3-benzazepines and their use for treating gastrointestinal motility disorders |
| GB8807922D0 (en) * | 1988-04-05 | 1988-05-05 | Fujisawa Pharmaceutical Co | Isoquinoline compound & process for preparation thereof |
-
1988
- 1988-03-23 ZA ZA882080A patent/ZA882080B/xx unknown
- 1988-03-23 PH PH36675A patent/PH27337A/en unknown
- 1988-03-24 MY MYPI88000305A patent/MY103357A/en unknown
- 1988-03-24 EP EP88903596A patent/EP0357641A1/en active Pending
- 1988-03-24 HU HU882812A patent/HU205744B/hu not_active IP Right Cessation
- 1988-03-24 KR KR1019880701534A patent/KR930011489B1/ko not_active IP Right Cessation
- 1988-03-24 EP EP88104758A patent/EP0285919B1/en not_active Expired - Lifetime
- 1988-03-24 CA CA000562352A patent/CA1321195C/en not_active Expired - Fee Related
- 1988-03-24 JP JP63503399A patent/JPH0662574B2/ja not_active Expired - Lifetime
- 1988-03-24 AT AT88104758T patent/ATE112766T1/de not_active IP Right Cessation
- 1988-03-24 AU AU15964/88A patent/AU619744B2/en not_active Ceased
- 1988-03-24 IL IL85855A patent/IL85855A/xx not_active IP Right Cessation
- 1988-03-24 WO PCT/US1988/000899 patent/WO1988007526A1/en not_active Application Discontinuation
- 1988-03-24 DE DE3851769T patent/DE3851769T2/de not_active Expired - Fee Related
- 1988-03-24 PT PT87068A patent/PT87068B/pt not_active IP Right Cessation
- 1988-03-25 NZ NZ224038A patent/NZ224038A/xx unknown
- 1988-11-15 NO NO885096A patent/NO174507B/no unknown
- 1988-11-23 DK DK652688A patent/DK165688C/da active
-
1989
- 1989-09-27 FI FI894566A patent/FI894566A0/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU619744B2 (en) | 1992-02-06 |
| EP0285919B1 (en) | 1994-10-12 |
| NO174507C (pt) | 1994-05-18 |
| KR890700577A (ko) | 1989-04-25 |
| HUT53882A (en) | 1990-12-28 |
| PH27337A (en) | 1993-06-08 |
| KR930011489B1 (ko) | 1993-12-08 |
| FI894566A (fi) | 1989-09-27 |
| NZ224038A (en) | 1990-10-26 |
| DE3851769T2 (de) | 1995-03-09 |
| EP0357641A1 (en) | 1990-03-14 |
| HU205744B (en) | 1992-06-29 |
| JPH0662574B2 (ja) | 1994-08-17 |
| NO885096L (no) | 1988-11-15 |
| DK652688D0 (da) | 1988-11-23 |
| DK165688C (da) | 1993-05-24 |
| IL85855A (en) | 1993-02-21 |
| JPH02502723A (ja) | 1990-08-30 |
| MY103357A (en) | 1993-06-30 |
| ZA882080B (en) | 1989-04-26 |
| EP0285919A1 (en) | 1988-10-12 |
| ATE112766T1 (de) | 1994-10-15 |
| AU1596488A (en) | 1988-11-02 |
| WO1988007526A1 (en) | 1988-10-06 |
| CA1321195C (en) | 1993-08-10 |
| PT87068B (pt) | 1992-07-31 |
| FI894566A0 (fi) | 1989-09-27 |
| DK652688A (da) | 1988-11-23 |
| NO885096D0 (no) | 1988-11-15 |
| NO174507B (no) | 1994-02-07 |
| DK165688B (da) | 1993-01-04 |
| IL85855A0 (en) | 1988-09-30 |
| DE3851769D1 (de) | 1994-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT87068A (pt) | Process for preparing substituted benzazepines and pharmaceutical compositions containing them | |
| PH23607A (en) | Amide derivatives and pharmaceutical composition containing said compounds | |
| DE69332577T2 (de) | Verfahren zur Herstellung von 13-Ether-Derivaten von Milbemycinen und Zwischenprodukte | |
| DE3873578D1 (de) | Verwendung von tetrahydrobenz(c,d)indol-6-carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden. | |
| AU1832988A (en) | Thiazole derivatives | |
| GB8925032D0 (en) | Chemical compounds | |
| ATE69448T1 (de) | Chinolincarbonsaeure-derivate, diese enthaltende zusammensetzung, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von medikamenten. | |
| DE69309461T2 (de) | Zusammensetzung zur Beschleunigung der Wundheilung | |
| PT84367A (en) | Process for the preparation of a fungicidal compound containing a naphthimidezolone | |
| DE69107561T2 (de) | Verfahren zur Herstellung von 4-Methylsulfonylbenzoesäurederivate und Zwischenprodukte. | |
| HUT54688A (en) | Process for producing compounds utilizable for treating ulcus and pharmaceutical compositions containing them as active components | |
| ATE30911T1 (de) | Hydrazinopyridazinverbindung, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
| ES2044883T3 (es) | Procedimiento para preparar quinoxalinas sustituidas. | |
| DE69129605D1 (de) | Verfahren zur Herstellung von N-Alkylpyrazolen | |
| ES8307831A1 (es) | Procedimiento para preparar nuevos derivados organofosfora- dos. | |
| MY103596A (en) | Insecticidal compounds - characterised by enhanced knockdown effect. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG3A | Patent granted, date of granting |
Effective date: 19920128 |
|
| MM3A | Annulment or lapse |
Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 19960731 |